Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Genomics Market, by Product & Service
1.4.2 Europe Genomics Market, by Application
1.4.3 Europe Genomics Market, by End User
1.4.4 Europe Genomics Market, by Technology
1.4.5 Europe Genomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2017, Jan – 2021, Dec) Leading Players
Chapter 4. Europe Genomics Market by Product & Service
4.1 Europe Consumables Market by Country
4.2 Europe Systems & Software Market by Country
4.3 Europe Services Market by Country
Chapter 5. Europe Genomics Market by Application
5.1 Europe Drug Discovery & Development Market by Country
5.2 Europe Diagnostics Market by Country
5.3 Europe Agriculture & Animal Research Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Genomics Market by End User
6.1 Europe Hospitals & Clinics Market by Country
6.2 Europe Research Centers and Academic & Government Institutes Market by Country
6.3 Europe Pharmaceutical & Biotechnology Companies Market by Country
6.4 Europe Others Market by Country
Chapter 7. Europe Genomics Market by Technology
7.1 Europe Sequencing Market by Country
7.2 Europe PCR Market by Country
7.3 Europe Nucleic Acid Extraction & Purification Market by Country
7.4 Europe Microarray Market by Country
7.5 Europe Others Market by Country
Chapter 8. Europe Genomics Market by Country
8.1 Germany Genomics Market
8.1.1 Germany Genomics Market by Product & Service
8.1.2 Germany Genomics Market by Application
8.1.3 Germany Genomics Market by End User
8.1.4 Germany Genomics Market by Technology
8.2 UK Genomics Market
8.2.1 UK Genomics Market by Product & Service
8.2.2 UK Genomics Market by Application
8.2.3 UK Genomics Market by End User
8.2.4 UK Genomics Market by Technology
8.3 France Genomics Market
8.3.1 France Genomics Market by Product & Service
8.3.2 France Genomics Market by Application
8.3.3 France Genomics Market by End User
8.3.4 France Genomics Market by Technology
8.4 Russia Genomics Market
8.4.1 Russia Genomics Market by Product & Service
8.4.2 Russia Genomics Market by Application
8.4.3 Russia Genomics Market by End User
8.4.4 Russia Genomics Market by Technology
8.5 Spain Genomics Market
8.5.1 Spain Genomics Market by Product & Service
8.5.2 Spain Genomics Market by Application
8.5.3 Spain Genomics Market by End User
8.5.4 Spain Genomics Market by Technology
8.6 Italy Genomics Market
8.6.1 Italy Genomics Market by Product & Service
8.6.2 Italy Genomics Market by Application
8.6.3 Italy Genomics Market by End User
8.6.4 Italy Genomics Market by Technology
8.7 Rest of Europe Genomics Market
8.7.1 Rest of Europe Genomics Market by Product & Service
8.7.2 Rest of Europe Genomics Market by Application
8.7.3 Rest of Europe Genomics Market by End User
8.7.4 Rest of Europe Genomics Market by Technology
Chapter 9. Company Profiles
9.1 Creative Biogene
9.1.1 Company Overview
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.6 SWOT Analysis
9.3 Illumina, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Acquisition and Mergers:
9.4 Bio-Rad laboratories, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 Danaher Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.6 Agilent Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.5.3 Acquisition and Mergers:
9.7 F. Hoffmann-La Roche Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Product Launches and Product Expansions:
9.7.5.3 Acquisition and Mergers:
9.8 Eurofins Scientific Group
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Acquisition and Mergers:
9.9 Qiagen N.V.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.9.5.3 Acquisition and Mergers:
9.10. New England BioLabs, Inc.
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Product Launches and Product Expansions:
Unique Offerings 
